Repro Med Systems (KRMD) Tops Q1 EPS by 2c

Repro Med Systems (NASDAQ: KRMD) reported Q1 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.23 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• BQE Water Announces Investor Call for Fall 2026
• Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"